Equities

ImmuPharma PLC

IMM:LSE

ImmuPharma PLC

Health CarePharmaceuticals and Biotechnology
  • Price (GBX)2.05
  • Today's Change0.009 / 0.44%
  • Shares traded395.86k
  • 1 Year change-33.80%
  • Beta2.4849
Data delayed at least 20 minutes, as of May 03 2024 12:31 BST.
More ▼

Forecasts data is unavailable for this security.

Share price forecast

The one analyst offering a 12 month price target expects ImmuPharma PLC share price to rise to 2.90 in the next year from the last price of 2.04.
High42.2%2.90
Med42.2%2.90
Low42.2%2.90

Earnings history & estimates

Annual earnings information is not available for ImmuPharma PLC.
Average growth rate+14.13%
More ▼

Revenue history & estimates

ImmuPharma plc did not report revenues for the full year 2022. However, during the prior year the company reported revenues of 118.00k.
Average growth rate-11.99%
More ▼
Data Provided by LSEG
All markets data located on InvestorsChronicle.co.uk is subject to the Investors Chronicle Terms & Condition
All content on InvestorsChronicle.co.uk is for your general information and use only and is not intended to address your particular requirements. In particular, the content does not constitute any form of advice, recommendation, representation, endorsement or arrangement by IC and is not intended to be relied upon by users in making (or refraining from making) any specific investment or other decisions.
Any information that you receive via Investors Chronicle is at best delayed intraday data and not "real time". Share price information may be rounded up/down and therefore not entirely accurate. Investors Chronicle is not responsible for any use of content by you outside its scope as stated in the Investors Chronicle Terms & Condition.